A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol

dc.contributor.authorMastall, Maximilian
dc.contributor.authorRoth, Patrick
dc.contributor.authorBink, Andrea
dc.contributor.authorFischer Maranta, Angela
dc.contributor.authorLäubli, Heinz
dc.contributor.authorHottinger, Andreas Felix
dc.contributor.authorHundsberger, Thomas
dc.contributor.authorMigliorini, Denis
dc.contributor.authorOchsenbein, Adrian
dc.contributor.authorSeystahl, Katharina
dc.contributor.authorImbach, Lukas
dc.contributor.authorHortobágyi, Tibor
dc.contributor.authorHeld, Leonhard
dc.contributor.authorWeller, Michael
dc.contributor.authorWirsching, Hans-Georg
dc.date.accessioned2025-04-07T13:13:33Z
dc.date.available2025-04-07T13:13:33Z
dc.date.issued2024
dc.date.oa2025-04-23
dc.date.pasync2025-04-23T23:08:34Z
dc.date.updated2025-04-07T13:13:33Z
dc.description.correctorkzs
dc.identifier.citationBmc Cancer. -24 : 1 (2024), p. 1-7. -(cikkazonosító)82. -BMC Cancer. - 1471-2407. - 1471-2407
dc.identifier.doihttp://dx.doi.org/10.1186/s12885-023-11797-z
dc.identifier.issn1471-2407
dc.identifier.opachttps://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM129344
dc.identifier.scopus85182461604
dc.identifier.urihttps://hdl.handle.net/2437/388925
dc.identifier.urlhttps://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11797-z
dc.identifier.wos001143873900006
dc.languageund
dc.rights.accessopen access journal
dc.rights.ownerszerző
dc.subject.mabOrvostudományok
dc.subject.mabKlinikai orvostudományok
dc.titleA phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol
dc.typefolyóiratcikk
dc.typeidegen nyelvű folyóiratközlemény külföldi lapban
Fájlok
Eredeti köteg (ORIGINAL bundle)
Megjelenítve 1 - 1 (Összesen 1)
Nincs kép
Név:
FILE_UP_0_Mastall et al_BMC Cancer_2024.pdf
Méret:
932.32 KB
Formátum:
Adobe Portable Document Format
Leírás:
kiadói változat